IDN 1965

Drug Profile

IDN 1965

Latest Information Update: 27 Nov 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Idun Pharmaceuticals
  • Class Hepatoprotectants; Indoles; Oligopeptides; Small molecules
  • Mechanism of Action Caspase inhibitors; Caspase-3 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Heart failure; Reperfusion injury

Most Recent Events

  • 19 Apr 2005 Idun Pharmaceuticals has been acquired by Pfizer
  • 20 Feb 2002 A preclinical study has been added to the Heart Failure pharmacodynamics section
  • 12 Nov 2000 Preclinical development for Heart failure in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top